Traws Pharma raises ~$20M in Dec 31 offering; believes it now meets Nasdaq equity minimum

Traws Pharma, Inc.

Closed Dec 31, 2024 unit offering; gross proceeds ~$20M, up to $52.6M more on warrant exercise.
Company now believes stockholders' equity is at least $2.5M, addressing Nasdaq Rule 5550(b)(1).
Awaiting Nasdaq confirmation; no assurance that compliance will be formally determined.
Hearing panel had granted exception until Feb 18, 2025; filing updates status.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.